BTAI
Price
$1.57
Change
-$0.20 (-11.30%)
Updated
Jun 13, 04:59 PM (EDT)
Capitalization
9.45M
INBX
Price
$14.61
Change
+$0.28 (+1.95%)
Updated
Jun 13, 04:59 PM (EDT)
Capitalization
210.91M
66 days until earnings call
Interact to see
Advertisement

BTAI vs INBX

Header iconBTAI vs INBX Comparison
Open Charts BTAI vs INBXBanner chart's image
BioXcel Therapeutics
Price$1.57
Change-$0.20 (-11.30%)
Volume$1.34K
Capitalization9.45M
Inhibrx Biosciences
Price$14.61
Change+$0.28 (+1.95%)
Volume$1.01K
Capitalization210.91M
BTAI vs INBX Comparison Chart
Loading...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BTAI vs. INBX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BTAI is a Hold and INBX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (BTAI: $1.77 vs. INBX: $14.33)
Brand notoriety: BTAI and INBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BTAI: 15% vs. INBX: 55%
Market capitalization -- BTAI: $9.45M vs. INBX: $210.91M
BTAI [@Biotechnology] is valued at $9.45M. INBX’s [@Biotechnology] market capitalization is $210.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BTAI’s FA Score shows that 0 FA rating(s) are green whileINBX’s FA Score has 2 green FA rating(s).

  • BTAI’s FA Score: 0 green, 5 red.
  • INBX’s FA Score: 2 green, 3 red.
According to our system of comparison, INBX is a better buy in the long-term than BTAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BTAI’s TA Score shows that 4 TA indicator(s) are bullish while INBX’s TA Score has 6 bullish TA indicator(s).

  • BTAI’s TA Score: 4 bullish, 5 bearish.
  • INBX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, INBX is a better buy in the short-term than BTAI.

Price Growth

BTAI (@Biotechnology) experienced а +15.69% price change this week, while INBX (@Biotechnology) price change was +11.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.05%. For the same industry, the average monthly price growth was +20.18%, and the average quarterly price growth was +6.33%.

Reported Earning Dates

INBX is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+8.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INBX($211M) has a higher market cap than BTAI($9.45M). INBX YTD gains are higher at: -6.948 vs. BTAI (-70.413). INBX has higher annual earnings (EBITDA): 1.73B vs. BTAI (-24.24M). INBX has more cash in the bank: 217M vs. BTAI (31M). BTAI (106M) and INBX (107M) have identical debt. BTAI has higher revenues than INBX: BTAI (1.85M) vs INBX (200K).
BTAIINBXBTAI / INBX
Capitalization9.45M211M4%
EBITDA-24.24M1.73B-1%
Gain YTD-70.413-6.9481,013%
P/E RatioN/A0.12-
Revenue1.85M200K926%
Total Cash31M217M14%
Total Debt106M107M99%
FUNDAMENTALS RATINGS
BTAI: Fundamental Ratings
BTAI
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BTAIINBX
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DWTX5.180.36
+7.47%
Dogwood Therapeutics Inc
SAMG15.110.01
+0.07%
Silvercrest Asset Management Group
VTS24.43N/A
N/A
Vitesse Energy
YUMC44.65-0.26
-0.58%
Yum China Holdings
FLYW10.79-0.09
-0.83%
Flywire Corp

BTAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BTAI has been loosely correlated with TENX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if BTAI jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BTAI
1D Price
Change %
BTAI100%
-1.12%
TENX - BTAI
37%
Loosely correlated
+1.83%
SYBX - BTAI
37%
Loosely correlated
+0.82%
CRSP - BTAI
34%
Loosely correlated
-0.58%
SBHMY - BTAI
32%
Poorly correlated
N/A
INBX - BTAI
30%
Poorly correlated
-2.38%
More

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with IMNM. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
-2.38%
IMNM - INBX
42%
Loosely correlated
+3.16%
ACET - INBX
38%
Loosely correlated
-0.62%
GBIO - INBX
37%
Loosely correlated
-2.05%
COGT - INBX
37%
Loosely correlated
-0.55%
IDYA - INBX
37%
Loosely correlated
+1.64%
More